Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus… - Cancer management …, 2010 - Taylor & Francis
Introduction The purpose of this study was to evaluate the clinical efficacy in our daily
practice, outside clinical trials, of cetuximab plus radiotherapy in a majority of treatment …

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus… - Cancer Management and …, 2010 - dovepress.com
Methods: A retrospective study was performed to evaluate outcomes in patients who were
treated definitively with cetuximab and radiotherapy (ExRT). Patients with stage III or IV …

[PDF][PDF] Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter - Cancer Management and Research, 2010 - pdfs.semanticscholar.org
Results: There were 18 males and two females. The median age was 61 years (range from
49 to 87 years old). Concurrent radiotherapy and cetuximab was used, in first line, in 17 …

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials.

D Dequanter, M Shahla, P Paulus… - Cancer Management and …, 2010 - europepmc.org
Methods A retrospective study was performed to evaluate outcomes in patients who were
treated definitively with cetuximab and radiotherapy (ExRT). Patients with stage III or IV …

[HTML][HTML] Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus… - Cancer management …, 2010 - ncbi.nlm.nih.gov
Methods: A retrospective study was performed to evaluate outcomes in patients who were
treated definitively with cetuximab and radiotherapy (ExRT). Patients with stage III or IV …

[PDF][PDF] Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter - Cancer Management and Research, 2010 - scholar.archive.org
Results: There were 18 males and two females. The median age was 61 years (range from
49 to 87 years old). Concurrent radiotherapy and cetuximab was used, in first line, in 17 …

[PDF][PDF] Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter - Cancer Management and Research, 2010 - Citeseer
Results: There were 18 males and two females. The median age was 61 years (range from
49 to 87 years old). Concurrent radiotherapy and cetuximab was used, in first line, in 17 …

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus, P Lothaire - Cancer Management and …, 2010 - osti.gov
The purpose of this study was to evaluate the clinical efficacy in our daily practice, outside
clinical trials, of cetuximab plus radiotherapy in a majority of treatment-naive patients with …

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus… - Cancer management …, 2010 - pubmed.ncbi.nlm.nih.gov
Introduction The purpose of this study was to evaluate the clinical efficacy in our daily
practice, outside clinical trials, of cetuximab plus radiotherapy in a majority of treatment …

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

D Dequanter, M Shahla, P Paulus… - Cancer Management and …, 2010 - inis.iaea.org
[en] The purpose of this study was to evaluate the clinical efficacy in our daily practice,
outside clinical trials, of cetuximab plus radiotherapy in a majority of treatment-naive patients …